Skip to main content

Stephen Willie

Analyst

Stifel

Equibles does not estimate personal net worth.

About Stephen Willie

Stephen Willie is recorded as Analyst at Stifel. Stephen Willie has spoken on 2 investor events across 1 company, most recently for Candel Therapeutics, Inc. on November 10, 2026. The companies whose calls Stephen Willie spoke on are classified in the Healthcare sector.

Stephen Willie on recent calls

“So let's jump into aglatimogene for localized prostate cancer. Maybe we can just start off with the PRTK05 data you just presented at CITSI. I know the mechanism of this drug is pretty unique.”
Analyst — Stifel, Stifel 2026 Healthcare Conference ·
“So let's jump into aglatimogene for localized prostate cancer. Maybe we can just start off with the PRTK05 data you just presented at CITSI. I know the mechanism of this drug is pretty unique.”
Analyst — Stifel, Stifel 2026 Healthcare Conference (New York, NY) ·

Affiliation history

  • Stifel

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity